TABLE-Pharma Foods Int'l <2929.T>-2009/10 parentThu, 9 Sep 2010 07:28:00 GMT Sept 9 (Reuters) - PHARMA FOODS INTERNATIONAL CO LTD PARENT-ONLY EARNINGS ESTIMATES (in billions of yen unless specified) Full year to Full year to July 31,2010 July 31,2010 LATEST PREVIOUS FORECAST FORECAST Sales 959 mln 955 mln Operating loss 63 mln
Alexion Pharmaceuticals Rises 2.29% on Heavy Volume: Watch For Pullback (ALXN)Thu, 9 Sep 2010 07:27:00 GMT Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $57.97 to a high of $59.36. Yesterday, the shares gained 2.29%, which took the trading range above the 3-day high of $58.70 on volume of 704,000 shares. Shares
GlaxoSmithKline Set to Pullback after Yesterday's Rally of 0.49% (GSK)Thu, 9 Sep 2010 07:27:00 GMT GlaxoSmithKline (NYSE:GSK) traded in a range yesterday that spanned from a low of $39.04 to a high of $39.48. Yesterday, the shares gained 0.49%, which took the trading range above the 3-day high of $39.31 on volume of 1.2 million shares. Shares of
NovaBay Pharmaceuticals to deliver data on Aganocide compounds at ICAAC ConferenceThu, 9 Sep 2010 07:21:00 GMT NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its
Emergent Biosolutions gets regulatory nod to buy Trubion PharmaceuticalsThu, 9 Sep 2010 07:16:00 GMT US biopharmaceutical company Emergent Biosolutions (NYSE: EBS | PowerRating For full details on Emergent BioSolutions Inc (EBS) EBS. Emergent BioSolutions Inc (EBS) has Short Term PowerRatings at TradingMarkets. Details on Emergent BioSolutions Inc (EBS)
BioMarin Pharmaceutical In Retrospect: Shares Up 5.32% Since Upgraded One-Week Ago (BMRN)Thu, 9 Sep 2010 07:12:00 GMT One week ago, BioMarin Pharmaceutical (NASDAQ:BMRN) was upgraded to Buy from Hold, $25 target, at Morgan Joseph. The stock closed yesterday at $21.58 which is 5.32% higher than the price one-week ago of $20.49. BioMarin Pharmaceutical is currently above
Oasmia Pharmaceutical AB: Interim report for the period May - July 2010Thu, 9 Sep 2010 06:54:00 GMT Oasmia Pharmaceutical AB (publ) Interim report for the period May - July 2010 PHASE III STUDY WITH PACCAL® VET COMPLETED THE QUARTER IN BRIEF May 1 2010 - July 31 2010 Consolidated net sales amounted to TSEK 42 (24 657) Operating income amounted to
Schering 483 Notes CoA Validation IssuesThu, 9 Sep 2010 06:47:00 GMT A Form 483 to Schering Corporation notes the company failed to establish the reliability of a component supplier’s report of analyses, as test results are not appropriately validated at appropriate intervals.
GMP Deviations at Sanofi Plant Lead to Untitled LetterThu, 9 Sep 2010 06:47:00 GMT Sanofi Pasteur SA has received an FDA untitled letter after failure to report biological product deviations, control microbial contamination and establish control systems to prevent contamination or product mix-ups.
J&J Reorganizes Quality Control After Major OTC RecallThu, 9 Sep 2010 06:47:00 GMT Johnson & Johnson (J&J) is continuing efforts to stem the tide of problems resulting from its major OTC products recall earlier this year by reorganizing its quality control operations to provide greater manufacturing oversight.
Redundancies likely at Schering-Plough in CorkThu, 9 Sep 2010 06:43:00 GMT Workers at a pharmaceutical plant in west Cork have been called to a meeting later today at which plans for the future of the plant are expected to be revealed. It is understood that management at Schering-Plough near Innishannon, which employs 500
Schering-Plough workers braced for bad newsThu, 9 Sep 2010 06:43:00 GMT Workers at a pharmaceutical plant in West Cork have been called to a meeting later today at which plans for the future of the plant are expected to be revealed. It is understood that management at Schering-Plough, near Innishannon, will be seeking a
Fears for jobs at Cork pharma plantThu, 9 Sep 2010 06:39:00 GMT There are fears for at one of the longest established pharmaceutical plants in the country.Staff at Schering Plough near Innishannon in Co Cork have been called to a meeting with management at the plant this afternoon.Some 516 people work at the biotech
SmarTrend Watching for Pullback in Shares of Novartis After 0.32% Gain (NVS)Thu, 9 Sep 2010 06:24:00 GMT Novartis (NYSE:NVS) traded in a range yesterday that spanned from a low of $53.42 to a high of $53.77. Yesterday, the shares gained 0.32%, which took the trading range above the 3-day high of $53.40 on volume of 2.4 million shares. Shares of Novartis are
Shanghai Pharma to launch Hong Kong IPOThu, 9 Sep 2010 06:01:00 GMT Shanghai. September 9. INTERFAX-CHINA - Shanghai Pharmaceuticals Holding Co. Ltd. plans to launch an initial public offering (IPO) on the Hong Kong Stock Exchange to fund expansion, the company announced Sept. 9.
J&J to stop selling a Basilea drug in SwitzerlandThu, 9 Sep 2010 05:58:00 GMT Story Quotes Comments Screener AlertEmail Print By Robert Daniel BPMUFCH:BSLN JNJ TEL AVIV (MarketWatch) -- A Johnson & Johnson subsidiary will stop selling in Switzerland the drug Zevtera to treat skin and soft-tissue infections, 'based on the
Look for Shares of Merck to Pullback after Yesterday's 0.99% Rise (MRK)Thu, 9 Sep 2010 05:47:00 GMT Merck (NYSE:MRK) traded in a range yesterday that spanned from a low of $35.34 to a high of $36.00. Yesterday, the shares gained 0.99%, which took the trading range above the 3-day high of $35.84 on volume of 8.4 million shares. Shares of Merck are
Infinity Pharmaceuticals to Present at Two Upcoming ConferencesThu, 9 Sep 2010 05:35:00 GMT CAMBRIDGE, Mass., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Rodman & Renshaw Annual Global Investment Conference in New York on Wednesday, September 15, 2010 at 11:40 a.m. EDT. In addition,
Accord Pharma To Purchase 52.6% Stake In Sinopharm Chinese M...Thu, 9 Sep 2010 05:28:00 GMT September 9 -- Shenzhen Accord Pharmaceutical (000028) may purchase a 52.61 percent stake in Sinopharm Traditional Chinese Medicine from its effective controller, China National Pharmaceutical Group Corporation (Sinopharm), for 27.14 million yuan,
Onyx Pharma licenses two cancer drugs to Ono in JapanThu, 9 Sep 2010 05:13:00 GMT Onyx Pharmaceuticals has licensed Ono Pharmaceutical for the development and commercialisation of two of its compounds, carfilzomib and ONX 0912 from proteasome inhibitor development program. The deal valued at more than $300m, plus potential royalties.
Ariana Pharma to offer KEM biomarker technology to FDAThu, 9 Sep 2010 05:13:00 GMT Ariana Pharma is set to offer its KEM (Knowledge Extraction Management) biomarker technology to FDA to facilitate data analysis for the validation of biomarker signatures. KEM platform, a rules-based method, has been developed by Ariana Pharma to mine
CSR Activities of Members
Print
Friendly
Webmaster